FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Vet Intern Med / Risk factors for recurrence of atrial fibrillation in horses...
Journal of veterinary internal medicine2015; 29(3); 946-953; doi: 10.1111/jvim.12606

Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm.

Abstract: Although atrial fibrillation (AF) can be successfully treated in horses, recurrence occurs frequently. In humans, atrial function after cardioversion can predict recurrence. Objective: To examine the prognostic value of atrial mechanical function at 24 hours after cardioversion and other potential predictor variables for AF recurrence in horses. Methods: 117 horses treated for AF at 4 referral centers. Methods: Retrospective study. Inclusion criteria were successful cardioversion, echocardiography at 24 hours after cardioversion and ≥4 months follow-up. To determine factors associated with AF recurrence, a multivariable survival model was built. Results: 133 AF episodes in 117 horses were included. AF recurred in 36/100 horses with a first AF episode and in 57/133 AF episodes overall. Factors associated with recurrence in horses with a first episode were previous unsuccessful treatment attempt (hazard ratio HR 2.36, 95% confidence interval CI 1.11-4.99, P = .025) and mild or moderate mitral regurgitation (HR 2.70, 95% CI 1.23-5.91, P = .013). When the last AF episode of all horses was included, previous AF (HR 2.53, 1.33-4.82, P = .005) and active left atrial fractional area change ≤9.6% (HR 3.43, 1.22-9.67, P = .020) were significant predictors. Conclusions: The only echocardiographic variable of left atrial function with significant prognostic value for recurrence was low active left atrial fractional area change. Further research is necessary to evaluate whether echocardiography at a later timepoint could provide more prognostic information.
Copyright © 2015 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
Get Full Text
Publication Date: 2015-04-27 PubMed ID: 25917409PubMed Central: PMC4895430DOI: 10.1111/jvim.12606Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the factors contributing to the recurrence of atrial fibrillation in horses after undergoing a certain heart procedure called cardioversion. It concluded that prior unsuccessful treatment attempts, mild or moderate mitral regurgitation, and a low active left atrial fractional area change are key indicators of recurrence.

Objective and Methodology

  • The research sought to identify the predictors of atrial fibrillation (AF) recurrence in horses after they have been treated through cardioversion.
  • The researchers utilized a retrospective study where they included cases of 117 horses who had received treatment for AF at four referral centers.
  • The horses must have successfully underwent cardioversion, had an echocardiography 24 hours after cardioversion, and had a minimum follow-up period of four months in order to qualify for the study.
  • The researchers then built a multivariable survival model to determine the factors that were associated with the recurrence of AF.

Results

  • The study included a total of 133 AF episodes from the 117 horses. Of these, recurrence of AF was found in 36 of the 100 horses experiencing their first AF episode, and in 57 of the 133 total AF occurrences.
  • The study found that in horses experiencing their first AF episode, factors such as having had a previous unsuccessful treatment attempt and exhibiting mild or moderate mitral regurgitation were associated with AF recurrence.
  • When considering the last AF episode of all horses, previous occurrence of AF and an active left atrial fractional area change of less than or equal to 9.6% were found to be significant predictors of recurrence.

Conclusion

  • The only echocardiographic variable of left atrial function that held significant prognostic value for predicting recurrence was a low active left atrial fractional area change.
  • The researchers suggest that further studies need to be carried out to determine if conducting echocardiography at a later timepoint could provide more valuable prognostic information.

Cite This Article

APA
Decloedt A, Schwarzwald CC, De Clercq D, Van Der Vekens N, Pardon B, Reef VB, van Loon G. (2015). Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm. J Vet Intern Med, 29(3), 946-953. https://doi.org/10.1111/jvim.12606

Publication

Journal of veterinary internal medicine
ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 29
Issue: 3
Pages: 946-953

Researcher Affiliations

Decloedt, A
  • Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, 9820, Belgium.
Schwarzwald, C C
  • Clinic for Equine Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, 8057, Switzerland.
  • Department of Veterinary Clinical Sciences, The Ohio State University, Columbus, OH, 43210.
De Clercq, D
  • Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, 9820, Belgium.
Van Der Vekens, N
  • Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, 9820, Belgium.
Pardon, B
  • Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, 9820, Belgium.
Reef, V B
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, PA, 19348.
van Loon, G
  • Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, 9820, Belgium.

MeSH Terms

  • Animals
  • Atrial Fibrillation / etiology
  • Atrial Fibrillation / therapy
  • Atrial Fibrillation / veterinary
  • Echocardiography / veterinary
  • Electric Countershock / veterinary
  • Female
  • Horse Diseases / etiology
  • Horse Diseases / therapy
  • Horses
  • Male
  • Prognosis
  • Recurrence
  • Retrospective Studies
  • Risk Factors

References

This article includes 39 references
  1. Reef VB, Bonagura J, Buhl R. Recommendations for Management of Equine Athletes with Cardiovascular Abnormalities. J Vet Intern Med 2014;28:749–761.
    pmc: PMC4895474pubmed: 24628586
  2. Verheyen T, Decloedt A, van der Vekens N. Ventricular response during lungeing exercise in horses with lone atrial fibrillation. Eq Vet J 2013;45:309–314.
    pubmed: 23094848
  3. Gerber H, Chuit P, Schatzmann HJ. Treatment of atrial fibrillation in the horse with intravenous dihydroquinidine gluconate. Eq Vet J 1971;3:110–113.
    pubmed: 5161362
  4. Reef VB, Reimer JM, Spencer PA. Treatment of atrial fibrillation in horses: new perspectives. J Vet Intern Med 1995;9:57–67.
    pubmed: 7760311
  5. van Loon G, Blissitt KJ, Keen JA. Use of intravenous flecainide in horses with naturally‐occurring atrial fibrillation. Eq Vet J 2004;36:609–614.
    pubmed: 15581326
  6. De Clercq D, van Loon G, Baert K. Intravenous amiodarone treatment in horses with chronic atrial fibrillation. Vet J 2006;172:129–134.
    pubmed: 15908245
  7. Risberg AI, McGuirk SM. Successful conversion of equine atrial fibrillation using oral flecainide. J Vet Intern Med 2006;20:207–209.
    pubmed: 16496944
  8. De Clercq D, van Loon G, Baert K. Effects of an adapted intravenous amiodarone treatment protocol in horses with atrial fibrillation. Eq Vet J 2007;39:344–349.
    pubmed: 17722727
  9. Reef VB, Levitan CW, Spencer PA. Factors affecting prognosis and conversion in equine atrial fibrillation. J Vet Intern Med 1988;2:1–6.
    pubmed: 3221350
  10. Deem DA, Fregin GF. Atrial fibrillation in horses: a review of 106 clinical cases, with consideration of prevalence, clinical signs, and prognosis. J Am Vet Med Assoc 1982;180:261–265.
    pubmed: 7056674
  11. Morris DD, Fregin GF. Atrial fibrillation in horses: factors associated with response to quinidine sulfate in 77 clinical cases. Cornell Vet 1982;72:339–349.
    pubmed: 6754252
  12. McGurrin MK, Physick‐Sheard PW, Kenney DG. Transvenous electrical cardioversion of equine atrial fibrillation: patient factors and clinical results in 72 treatment episodes. J Vet Intern Med 2008;22:609–615.
    pubmed: 18466256
  13. De Clercq D, van Loon G, Schauvliege S. Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters. Vet J 2008;177:198–204.
    pubmed: 17920965
  14. Decloedt A, De Clercq D, van der Vekens N. Non‐invasive determination of atrial fibrillation cycle length by atrial color tissue Doppler imaging in horses. Eq Vet J 2013;46:174–179.
    pubmed: 23738919
  15. De Clercq D, van Loon G, Tavernier R. Atrial and ventricular electrical and contractile remodeling and reverse remodeling owing to short‐term pacing‐induced atrial fibrillation in horses. J Vet Intern Med 2008;22:1353–1359.
    pubmed: 19000247
  16. Schwarzwald CC, Schober KE, Bonagura JD. Echocardiographic evidence of left atrial mechanical dysfunction after conversion of atrial fibrillation to sinus rhythm in 5 horses. J Vet Intern Med 2007;21:820–827.
    pubmed: 17708405
  17. van Loon G. Effect of experimental chronic atrial fibrillation in equines. Atrial pacing and experimental atrial fibrillation in equines; PhD thesis. 2001:161–206.
  18. Schotten U, Verheule S, Kirchhof P. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Phys Rev 2011;91:265–325.
    pubmed: 21248168
  19. Decloedt A, Verheyen T, Van Der Vekens N. Long‐term follow‐up of atrial function after cardioversion of atrial fibrillation in horses. Vet J 2013;197:583–588.
    pubmed: 23823082
  20. Park SM, Kim YH, Choi JI. Left atrial electromechanical conduction time can predict six‐month maintenance of sinus rhythm after electrical cardioversion in persistent atrial fibrillation by Doppler tissue echocardiography. J Am Soc Echocardiogr 2010;23:309–314.
    pubmed: 20138472
  21. Goltz A, Gehlen H, Rohn K. Therapy of atrial fibrillation with class‐1A and class‐1C antiarrhythmic agents and ACE inhibitors. Pferdeheilk 2009;25:220–227.
  22. De Clercq D, Decloedt A, Sys S. Atrial fibrillation cycle length and atrial size in horses with and without recurrence of atrial fibrillation within one year after electrical cardioversion. J Vet Intern Med 2014;28:624–629.
    pmc: PMC4858013pubmed: 24611990
  23. Schwarzwald CC, Schober KE, Bonagura JD. Methods and reliability of echocardiographic assessment of left atrial size and mechanical function in horses. Am J Vet Res 2007;68:735–747.
    pubmed: 17605609
  24. Reef VB. Advances in echocardiography. Vet Clin North Am Eq Pract 1991;7:435–450.
    pubmed: 1933572
  25. Bouckaert S, Voorspoels J, Vandenbossche G. Effect of drug formulation and feeding on the pharmacokinetics of orally administered quinidine in the horse. J Vet Pharmacol Ther 1994;17:275–278.
    pubmed: 7966546
  26. Angelakos ET, Hastings EP. The influence of quinidine and procaine amide on myocardial contractility in vivo. Am J Cardiol 1960;5:791–798.
    pubmed: 13793666
  27. Yang Q, Padrini R, Piovan D. Cardiac effects of quinidine on guinea‐pig isolated perfused hearts after in vivo quinidine pretreatment. Br J Pharmacol 1997;122:7–12.
    pmc: PMC1564892pubmed: 9298522
  28. Tande PM, Refsum H. Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro. Pharmacol Toxicol 1990;66:18–22.
    pubmed: 2308902
  29. Trachsel D, Tschudi P, Portier CJ. Pharmacokinetics and pharmacodynamic effects of amiodarone in plasma of ponies after single intravenous administration. Toxicol Appl Pharmacol 2004;195:113–125.
    pubmed: 14962511
  30. De Clercq D, Baert K, Croubels S. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses. Am J Vet Res 2006;67:448–454.
    pubmed: 16506906
  31. Leung DY, Boyd A, Ng AA. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. Am Heart J 2008;156:1056–1064.
    pubmed: 19032999
  32. Borg AN, Harrison JL, Argyle RA. Left ventricular filling and diastolic myocardial deformation in chronic primary mitral regurgitation. Eur J Echocardiogr 2010;11:523–529.
    pubmed: 20185526
  33. Climent V, Marin F, Monmeneu JV. Atrial stunning as predictor of early relapse into atrial fibrillation after cardioversion. Int J Cardiol 2006;110:427–428.
    pubmed: 16378649
  34. De Vos CB, Weijs B, Crijns HJ. Atrial tissue Doppler imaging for prediction of new‐onset atrial fibrillation. Heart 2009;95:835–840.
    pubmed: 19074923
  35. Merckx KL, De Vos CB, Palmans A. Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation. J Am Soc Echocardiogr 2005;18:940–944.
    pubmed: 16153518
  36. van Loon G, Duytschaever M, Tavernier R. An equine model of chronic atrial fibrillation: methodology. Vet J 2002;164:142–150.
    pubmed: 12359469
  37. van Loon G, Tavernier R, Duytschaever M. Pacing induced sustained atrial fibrillation in a pony. Can J Vet Res 2000;64:254–258.
    pmc: PMC1189629pubmed: 11041507
  38. Reef VB, Bain FT, Spencer PA. Severe mitral regurgitation in horses: clinical, echocardiographic and pathological findings. Eq Vet J 1998;30:18–27.
    pubmed: 9458395
  39. Buhl R, Ersboll AK, Eriksen L. Sources and magnitude of variation of echocardiographic measurements in normal standardbred horses. Vet Radiol Ultrasound 2004;45:505–512.
    pubmed: 15605839
Subscribe to our newsletter
Join 99,383 horse owners like you who receive our email updates on horse health and nutrition.